naftopidil has been researched along with mdv 3100 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Deng, ZA; Lv, DJ; Qian, YN; Shen, JL; Tian, XM; Wang, CL; Yu, YZ; Yuan, M; Zhang, HB; Zhang, JX; Zhao, SC | 1 |
1 other study(ies) available for naftopidil and mdv 3100
Article | Year |
---|---|
Synthesis and biological evaluation of arylpiperazine derivatives as potential anti-prostate cancer agents.
Topics: Androgen Receptor Antagonists; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Humans; Male; Molecular Docking Simulation; Molecular Structure; Piperazines; Prostatic Neoplasms; Receptors, Androgen; Structure-Activity Relationship | 2019 |